Visudrisone
Visudrisone Brand names, Visudrisone Analogs
Visudrisone Brand Names Mixture
- No information avaliable
Visudrisone Chemical_Formula
C17H25N3O5S
Visudrisone RX_link
http://www.rxlist.com/cgi/generic2/meropen.htm
Visudrisone fda sheet
Visudrisone msds (material safety sheet)
Visudrisone Synthesis Reference
No information avaliable
Visudrisone Molecular Weight
383.464 g/mol
Visudrisone Melting Point
No information avaliable
Visudrisone H2O Solubility
Sparingly
Visudrisone State
Solid
Visudrisone LogP
0.33
Visudrisone Dosage Forms
Powder for solution (for injection)
Visudrisone Indication
For use as single agent therapy for the treatment of the following infections when caused by susceptible isolates of the designated microorganisms: complicated skin and skin structure infections due to Staphylococcus aureus (b-lactamase and non-b-lactamase producing, methicillin-susceptible isolates only), Streptococcus pyogenes, Streptococcus agalactiae, viridans group streptococci, Enterococcus faecalis (excluding vancomycin-resistant isolates), Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis and Peptostreptococcus species; complicated appendicitis and peritonitis caused by viridans group streptococci, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Bacteroides fragilis, B. thetaiotaomicron, and Peptostreptococcus species. Also for use in the treatment of bacterial meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (b-lactamase and non-b-lactamase-producing isolates), and Neisseria meningitidis.
Visudrisone Pharmacology
Meropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria. Meropenem exerts its action by penetrating bacterial cells readily and interfering with the synthesis of vital cell wall components, which leads to cell death.
Visudrisone Absorption
No information avaliable
Visudrisone side effects and Toxicity
In mice and rats, large intravenous doses of meropenem (2200-4000 mg/kg) have been associated with ataxia, dyspnea, convulsions, and mortalities.
Visudrisone Patient Information
Visudrisone Organisms Affected
Enteric bacteria and other eubacteria
